154 related articles for article (PubMed ID: 9498827)
1. Paclitaxel as a component of initial chemotherapy of advanced ovarian cancer: is the controversy resolved.
Markman M
J Cancer Res Clin Oncol; 1998 Jan; 124(1):1-3. PubMed ID: 9498827
[No Abstract] [Full Text] [Related]
2. [Paclitaxel (Taxol)--drug of choice in ovarian cancer].
Fishman A
Harefuah; 1996 Apr; 130(8):557-60. PubMed ID: 8765885
[No Abstract] [Full Text] [Related]
3. [Choice of first-line chemotherapy for advanced ovarian cancer].
Tiuliandin SA
Vopr Onkol; 1999; 45(4):350-4. PubMed ID: 10532090
[No Abstract] [Full Text] [Related]
4. [Pharmacotherapy in ovarian carcinoma].
Pfisterer J; Du Bois A
MMW Fortschr Med; 2005 Oct; 147(43):34-6. PubMed ID: 16302419
[TBL] [Abstract][Full Text] [Related]
5. [Advanced cancer of the ovary. The paclitaxel-cisplatin combination as the first-line standard of treatment].
Pecorelli S
Recenti Prog Med; 1999 Jun; 90(6):338-41. PubMed ID: 10399475
[No Abstract] [Full Text] [Related]
6. Maintenance therapy for ovarian cancer: of Helsinki and Hippocrates.
McGuire WP
J Clin Oncol; 2009 Oct; 27(28):4633-4. PubMed ID: 19704055
[No Abstract] [Full Text] [Related]
7. Chemotherapy: Current drugs still have potential in advanced ovarian cancer.
Hogberg T
Nat Rev Clin Oncol; 2010 Apr; 7(4):191-3. PubMed ID: 20354543
[TBL] [Abstract][Full Text] [Related]
8. [First-line chemotherapy in advanced ovarian cancer].
Colombo N; Parma G; Caspani G; Donesana P; Marinetti E; Mangioni C
Tumori; 1999; 85(3 Suppl 1):S23-6. PubMed ID: 10542882
[No Abstract] [Full Text] [Related]
9. Re: randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results.
Atkins CD
J Natl Cancer Inst; 2000 Sep; 92(17):1446-7. PubMed ID: 10974091
[No Abstract] [Full Text] [Related]
10. Dose-dense paclitaxel in advanced ovarian cancer.
Kumar A; Hoskins PJ; Tinker AV
Clin Oncol (R Coll Radiol); 2015 Jan; 27(1):40-7. PubMed ID: 25455846
[TBL] [Abstract][Full Text] [Related]
11. [Taxol in the treatment of ovarian neoplasm].
Wang Y; Huang R; Huang H
Zhonghua Fu Chan Ke Za Zhi; 1999 Jul; 34(7):439-41. PubMed ID: 11360659
[No Abstract] [Full Text] [Related]
12. [The role of paclitaxel in the first line treatment of cancer of the ovary?].
Slimane K
Bull Cancer; 2003 Mar; 90(3):202-3. PubMed ID: 12803089
[No Abstract] [Full Text] [Related]
13. Study affirms primacy of paclitaxel-cisplatin in advanced ovarian cancer.
Am J Health Syst Pharm; 1996 Mar; 53(5):498. PubMed ID: 8697006
[No Abstract] [Full Text] [Related]
14. Chemotherapy for ovarian cancer: an evidence-based approach.
Geisler JP; Manahan KJ; Wiemann MC
Minerva Ginecol; 2004 Dec; 56(6):539-45. PubMed ID: 15729206
[TBL] [Abstract][Full Text] [Related]
15. [Role of docetaxel in the treatment of gastric cancer].
Cascinu S
Tumori; 2001; 87(6):A10-2. PubMed ID: 11995696
[No Abstract] [Full Text] [Related]
16. Recent advances in the management of women with ovarian cancer.
Eltabbakh GH
Minerva Ginecol; 2004 Feb; 56(1):81-9. PubMed ID: 14973412
[TBL] [Abstract][Full Text] [Related]
17. [Experience in first-line chemotherapy with paclitaxel for the treatment of ovarian carcinomas].
Pete I; Szánthó A; Mayer A; Thurzó L; Pulay T
Orv Hetil; 2003 May; 144(19):919-24. PubMed ID: 12809068
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel plus organoplatins: still the gold standard in advanced ovarian cancer?
Boccardo F; Miglietta L; Bruzzone M; Rubagotti A; Locatelli MC; Ragni N
Ann Oncol; 2001 Jul; 12(7):1023-4. PubMed ID: 11521789
[No Abstract] [Full Text] [Related]
19. [Docetaxel and ovarian cancer].
Ray-Coquard I
Bull Cancer; 2004 Feb; 91(2):159-65. PubMed ID: 15047455
[TBL] [Abstract][Full Text] [Related]
20. Platinum compounds and paclitaxel in advanced epithelial ovarian cancer.
Gadducci A; Brunetti I; Cosio S; Giannessi PG; Genazzani AR; Conte P
Anticancer Res; 1997; 17(6D):4703-8. PubMed ID: 9494592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
